Geletneky Karsten, Hartkopf Andreas D, Krempien Robert, Rommelaere Jean, Schlehofer Joerg R
Department of Neurosurgery, University of Heidelberg, Heidelberg 69120, Germany.
J Biomed Biotechnol. 2010;2010:350748. doi: 10.1155/2010/350748. Epub 2010 Mar 7.
To elucidate the influence of ionizing radiation (IR) on the oncolytic activity of Parvovirus H-1 (H-1PV) in human high-grade glioma cells.
Short term cultures of human high-grade gliomas were irradiated at different doses and infected with H-1PV. Cell viability was assessed by determining relative numbers of surviving cells. Replication of H-1PV was measured by RT-PCR of viral RNA, fluorescence-activated cell sorter (FACS) analysis and the synthesis of infectious virus particles. To identify a possible mechanism for radiation induced change in the oncolytic activity of H-1PV we performed cell cycle analyses.
Previous irradiation rendered glioma cells fully permissive to H-1PV infection. Irradiation 24 hours prior to H-1PV infection led to increased cell killing most notably in radioresistant glioma cells. Intracellular levels of NS-1, the main effector of H-1PV induced cytotoxicity, were elevated after irradiation. S-phase levels were increased one day after irradiation improving S-phase dependent viral replication and cytotoxicity.
This study demonstrates intact susceptibility of previously irradiated glioma-cells for H-1PV induced oncolysis. The combination of ionizing radiation followed by H-1PV infection increased viral cytotoxicity, especially in radioresistant gliomas. These findings support the ongoing development of a clinical trial of H-1PV in patients with recurrent glioblastomas.
阐明电离辐射(IR)对细小病毒H-1(H-1PV)在人高级别胶质瘤细胞中的溶瘤活性的影响。
对人高级别胶质瘤的短期培养物进行不同剂量的照射,然后用H-1PV感染。通过测定存活细胞的相对数量来评估细胞活力。通过病毒RNA的逆转录聚合酶链反应(RT-PCR)、荧光激活细胞分选仪(FACS)分析和感染性病毒颗粒的合成来测量H-1PV的复制。为了确定辐射诱导H-1PV溶瘤活性变化的可能机制,我们进行了细胞周期分析。
先前的照射使胶质瘤细胞对H-1PV感染完全敏感。在H-1PV感染前24小时进行照射导致细胞杀伤增加,在放射抗性胶质瘤细胞中尤为明显。照射后,H-1PV诱导细胞毒性的主要效应物NS-1的细胞内水平升高。照射一天后S期水平增加,改善了依赖S期的病毒复制和细胞毒性。
本研究表明,先前照射过的胶质瘤细胞对H-1PV诱导的溶瘤作用具有完整的敏感性。电离辐射后再进行H-1PV感染的联合应用增加了病毒的细胞毒性,尤其是在放射抗性胶质瘤中。这些发现支持了正在进行的H-1PV治疗复发性胶质母细胞瘤患者的临床试验的开展。